Single Dose

Founders

• Kiran Pai

Our Investment Thesis

Single Dose, is a digital aggregator platform designed to transform how physicians in India interact with pharmaceutical companies. With over nine lakh practicing doctors and more than fifty thousand new doctors entering the profession annually, pharma companies rely heavily on medical representatives to communicate drug updates, therapy information, and support. However, this model is increasingly inefficient, inconsistent, and intrusive, leaving many physicians without timely access to essential information.

Single Dose brings an on demand app based model to bridge this gap. Much like consumer platforms in other industries, it democratizes access by allowing doctors to receive drug updates, peer reviews, CME details, clinical resources, adverse drug reporting, patient education materials, and direct communication with pharma representatives all in one place, at their convenience.

For physicians, it saves time, eliminates the hassle of in clinic representative visits, and provides a wider range of accurate and timely resources. For pharma companies, it creates new physician reach and leads without additional manpower costs, while ensuring better engagement, transparency, and speed to market.

By digitizing interactions and integrating both online and offline channels, Single Dose enables more efficient, scalable, and cost effective engagement, aiming to reshape the physician and pharma relationship and modernize India’s healthcare communication ecosystem.